Nexgel (NXGLW) Cash & Equivalents Growth (1y) (2020 - 2025)
Nexgel (NXGLW) Cash & Equivalents Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -19.91% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -3.67% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -3.76% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 21.48% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -14.50% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -18.09% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 19.45% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 27.52% |
| 10 | Nexgel | 194,000.44 | -994,999.56 | 1.11 Mn | 135.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -41.45% |
| Sep 30, 2025 | -11.43% |
| Jun 30, 2025 | -32.18% |
| Mar 31, 2025 | -50.72% |
| Dec 31, 2024 | -33.07% |
| Sep 30, 2024 | -67.91% |
| Jun 30, 2024 | -71.04% |
| Mar 31, 2024 | 207.37% |
| Dec 31, 2023 | 145.23% |
| Sep 30, 2023 | 131.25% |
| Jun 30, 2023 | -16.49% |
| Mar 31, 2023 | -92.52% |
| Dec 31, 2022 | -91.75% |
| Sep 30, 2022 | 13.71% |
| Jun 30, 2022 | 1,057.07% |
| Mar 31, 2022 | 883.18% |
| Dec 31, 2021 | 41,618.75% |
| Sep 30, 2021 | 699.36% |
| Jun 30, 2021 | 63.95% |
| Mar 31, 2021 | 386.36% |